A new flavanone (2S)-7,4'-hydroxyl-6-(2'',3''-epoxy-3''-methylbutyl)flavanone (1), together with five known compounds (2-6) were isolated from EtOAcsoluble extract of seeds of Psoralea corylifolia. Their structures were elucidated on the basis of spectroscopic and physico-chemical analyses. All compounds were evaluated for in vitro inhibitory activity against α-glucosidase. Among them, new compound 1 was found to exhibit inhibitory activity on α-glucosidase with IC 50 value of 29.2 µM.
Diabetes mellitus is the world's largest endocrine disease which caused very high mortality rate among all endocrine system diseases. The recent International Diabetes Federation's report revealed that the current figure of 382 million people with diabetes worldwide is expected to rise to 592 million by 2035 [1] . Among two type diabetes, there are almost 95% diabetic patients suffer from type 2 diabetes [2] . And type 2 diabetes can cause several chronic complications such as retinopathy and nephropathy. At present, drugs used to treat type 2 diabetes have some limitations and side effects which cannot be ignored including hypoglycemia, liver and kidney failure, diarrhea and lactic acidosis [3] . Therefore, searching for new drug with lower toxicity and better effectiveness to treat type 2 diabetes is necessary. Previous studies have revealed that the α-glucosidase is an important target to treat type 2 diabetes [4] . Inhibiting α-glucosidase is effective for delaying glucose absorption and preventing the level of postprandial blood glucose. Now searching for α-glucosidase inhibitors derived from edible plant is becoming increasingly popular and we focused on the Psoralea corylifolia in this study.
Psoralea corylifolia L. (Leguminosae), belonging to the family of legumes, is an annual herbaceous plant distributed widely in Southeast Asia [5] . It is renowned as a polyphenol-rich plant and the dried seeds of P. corylifolia have been used as a Chinese traditional medicine for treating a large range of diseases such as asthma [6] , spermatorrhea [7] , bacterial infections [7] , gynecological bleeding [7] and osteoporosis [7] . Previous studies on P. corylifolia led to the isolation of bioactive constituents including coumarins [4] , flavonoids [8] and meroterpenoids [9] . Some compounds showed diverse and promising biological properties such as antioxidant [10] , antibacterial [11] , anti-inflammatory [12] . During the course of our search for α-glucosidase inhibitors from P. corylifolia, a new compound (2S)-7,4'-hydroxyl-6-(2'',3''-epoxy-3''-methylbutyl)flavanone along with five known compounds (2-6) was isolated from EtOAc extract of the seeds of P. corylifolia. Herein, we report the isolation, structural elucidation of a new compound and evaluation of α-glucosidase inhibitory activity about these compounds. (1H, s) . The flavanone skeleton of 1 was also supported by the comparison of its NMR data with that of 4. However, detailed examination of the 1D and 2D NMR spectrum revealed that the difference between 1 and 4 was the side chain of A ring. The 1 H NMR and 13 C NMR spectroscopic data revealed the presence of a side chain including a methylene (δ H 2.78; δ C 29.6), a oxygenated methine (δ H 2.90; δ C 63.6), a oxygenated quaternary carbon (δ C 58. (δ C 58.7), of H-5'' (δ H 1.26) to C-2'' (δ C 63.6) and C-3'' (δ C 58.7) established the structure of side chain. Compared with the structure of 5,7-dihydroxy-8-(2,3-epoxy-3-methylbutyl)flavanone [13] , the side chain of 2'',3''-epoxy-3''-methylbutyl could be further confirmed. The location of this side chain could be deduced by the key HMBC correlations of δ H H-1'' (δ H 2.78) to C-6 (δ C 122.0). Compound 1 possess asymmetric carbon center at C-2. The absolute configuration of C-2 was assigned as S by the CD spectrum, which had a positive Cotton effect near 329 nm and a negative Cotton effect near 300 nm. Thus, the structure of (2S)-7,4'-hydroxyl-6-(2'',3''-epoxy-3''-methylbutyl)flavanone was determined.
Along with (2S)-7,4'-hydroxyl-6-(2'',3''-epoxy-3''-methylbutyl) flavanone (1), five known compounds (2-6) ( Figure 1 ) were obtained from P. corylifolia. The known compounds were identified as coryaurone A (2), brosimacutin E (3), corylifolin (4), isoneobavaisoflavone (5), brosimacutin G (6) based on the NMR data [4, 7, 9, 14] .
All the isolated compounds were assayed for their inhibitory activity against α-glucosidase. The assay was carried out at different concentrations ranging from 10 to 250 μM. Compounds 1-3 and 6 possessed significant α-glucosidase inhibitory in a dose-dependent manner, and showed more potent inhibitory activity with IC 50 values ranging from 29.2 to 156.2 μM, than that of a positive control acarbose (214.1 μM). Among the isolates, compound 1 (IC 50 = 29.2 μM) displayed high inhibitory activity on α-glucosidase compared with compound 4 (IC 50 > 250 M), which indicated that the α-glucosidase inhibitory activity might be associated with the epoxide ring. In addition, compound 3 (IC 50 = 99.5 μM), which has the skeleton of flavanone, had higher inhibitory activity than 2 (IC 50 = 156.2 μM). It showed the flavanone compounds have potential research value of inhibiting α-glucosidase activity. Furthermore, compound 6 (IC 50 = 72.8 M) displayed more potent α-glucosidase inhibitory activity than 5 (IC 50 > 250 M). It indicated the presence of dihydrofuran ring might be responsible for α-glucosidase inhibitory activity.
In this study, above data may provide a basis for the development of new α-glucosidase inhibitors to treat type 2 diabetes and it is valuable for further investigation and optimization of this type flavone. Table 2 : Inhibitory effects of compounds 1-6 on α-glucosidase activity.
-Not shown inhibitory activity. a Positive control.
Experimental

General Experimental Procedures:
Optical rotations were determined with JASCO P-1020 polarimeter (JASCO, Tokyo, Japan). UV spectra were measured with a UV-160A spectrophotometer (Shimadzu, Tokyo, Japan). IR spectra were made on a Nicolet Magna 750 spectrometer with KBr discus. Nuclear magnetic resonance (NMR) spectra were obtained from a Varian Unity Inova 500 MHz spectrometer (Varian Unity Inova, Phoenix, USA) using TMS as the internal standard. Mass spectra were obtained on a QTOF2 high resolution mass spectrometer (Micromass, Wythenshawe, UK). CD spectrum was recorded with a Jasco CD-2095-plus circular dichroism detector (JASCO Corporation). Column chromatography was conducted using silica gel 60 (200 m particle size, Yantai Xinde Chemical Co., Ltd, Yantai, China) and RP-18 (150-63 m particle size, Merck, Darmstadt, Germany). TLC was performed with precoated silica gel GF 254 glass plates (Qingdao Haiyang Chemical Co. Ltd.). HPLC were carried out using a Waters 2535Q HPLC system fitted with a 2998 photodiode array detector (Waters, USA), and an Optima Pak  C 18 column (10×250 mm, 10 m particle size, Shiseido Fine Chemicals, Tokyo, Japan).
Plant Material: The seeds of P. corylifolia were collected in Guangyuan, Sichuan province, Republic of China, and authenticated by Professor Lei Zhang (College of Pharmacy, Sichuan University). A voucher specimen of the plant (No. 20160425) was deposited at Chengdu University of Traditional Chinese Medicine, Sichuan, China.
Extraction and Isolation:
The powder of dried seeds of P. corylifolia (2.0 kg) were extracted with 95% EtOH at room temperature for three days to give 571.5 g crude extract. This extract was suspended in H 2 O, partitioned successively with hexane, EtOAc and n-BuOH to afford hexane (99.1 g, yield, 17.3%), EtOAc (184.2 g, yield, 32.2%), n-BuOH (179.5 g, yield, 31.4%) and H 2 O (95.5 g, yield, 16.7%) soluble fractions, respectively. The EtOAc extract was determined as the target extract for the isolation of α-glucosidase inhibitors as it gave the strongest inhibition for α-glucosidase. Part of the EtOAc-soluble fraction (100.0 g) was subjected to silica gel column chromatography using a gradient of CH 2 Cl 2 -MeOH (from 200:1, 100:1, 50:1, 30:1 to 1:1), and was separated into 10 fractions (Fr.1-Fr.10). Fr.6 (15.4 g) was fractionated by column chromatography on silica gel using a gradient of CH 2 Cl 2 -MeOH (from 100:1, 50:1, 25:1, 30:1 10:1 to 1:1), and was separated into 9 fractions (Fr.6.1- Glucosidase inhibitory activity: α-Glucosidase inhibitory activity were measured as described previously with minor modifications [15] . α-Glucosidase activity were determined by adding 3mM pnitrophenyl-α-D-glucopyranoside (25 μL) and 0.2 U/mL α-glucosidase (25 μL) into the the sample solution (625 μL). Each reaction was carried out at 37℃ for 30 min and stopped by adding 0.1 M Na 2 CO 3 (380 μL). Enzymatic activity was quantified by measuring absorbance at 401 nm. One unit of α-glucosidase activity was defined as the amount of enzyme liberating p-nitrophenol (1.0 μM) per min. The inhibitory effects of the tested compounds were expressed as the concentrations that inhibited 50% of the enzyme activity (IC 50 ). Acarbose, a known α-glucosidase inhibitor, was used as positive control.
